Introduction to Chemiluminescence Imaging
Chemiluminescence is the process of converting the chemical energy into light that is discharged as a result of chemical reaction with limited emission of heat. In this process, several isotopic and fluorescence techniques can be detected sensitively and cost effectively. A good example of chemiluminescence is the luminol test where blood is indicated by luminescence when it comes in contact with iron in hemoglobin.
Chemiluminescence imaging is the process of capturing a series of images when identifying low abundance proteins. It allows accurate determination of western blots with real-time display. It is used in various biological assays to detect quantities of biomolecules and is also used to trace the inorganic ions.
Market Size and Forecast
Use of high HD camera for imaging makes the analysis more precise which is one of the factors responsible for growth of the market. The image provides comprehensive tools for simple and accurate analysis. This imaging system is gaining popularity in health care sector especially in cancer.
The global chemiluminescence imaging market is anticipated to witness a significant growth over the forecast period i.e. 2019-2027. The market is segmented by application type & end users. End use industry is further bifurcated into research and academic institutes, forensic laboratories, diagnostic laboratory and others, out of which, the diagnostic laboratory segment is anticipated to have leading shares on account of more number of imaging systems being used in this segment for various tests being done for the patients and also to know the minute details of the samples imaging systems in order to work more accurately.
The market is further segmented by application type into tumor markers, DNA hybridization, vitamin (vitB12), hormones (insulin, thyroxin, and estradiol), chemiluminescence immunoassay, western blotting, southern blotting, forensic sciences and others, out of which the hormones segment is anticipated to have significant growth on account of increase in hormonal imbalances among the population and as well as the need for more accuracy in the detection of those imbalances for proper curing.
Get more information on this report: Download Sample PDF
Chemiluminescence imaging market is demonstrating continuous innovations in test offerings and wide number of product offerings of large as well as local manufacturers. Besides this, the collaborations among different market players for superior technological advancements in test offerings is further strengthening the growth of the market. Continuous research and development activities are being carried out to expand the product offerings by the major market players. The method provides precise results, lower variation, and enhanced specificity. These factors are more likely to increase the growth of the market in the near future.
Growth Drivers
Increased adoption of technology across industries
Use of chemiluminescence imaging is increasing significantly across various sectors such as medical, forensic sciences, DNA and protein detection, and food industry and is expected to boost the growth of the market during the forecast period. Chemiluminescence imaging is also used in pharmaceutical industry especially in R&D by research institutes. Moreover, launch of new and innovated products have been a major factor responsible for the growth of the market. For instance, Pop-Bio Ltd., launched its Pop-Bio Imaging System that uses Advanced Progressive Imaging technology to capture images precisely at ultra-high sensitivity and resolution which increases the efficiency of this technique and can be used in wide range of applications such as UV, blue-light, visible light and chemiluminescence.
Restraints
Highly sensitive
Chemiluminescence imaging is highly sensitive which relies on an enzymatic reaction detected by CCD camera and displays image based on the amount of light produced as compared to fluorescent detection. This factor is likely to exhibit the market growth during the forecast period. Moreover, this technique has limited growth in the developing regions which may hinder the growth of this market in Asia Pacific and Middle East region.
Market Segmentation
Our-in depth analysis of the chemiluminescence imaging market includes the following segments:
By Application type
- Tumor Markers
- DNA hybridization
- Vitamin (VitB12)
- Hormones (insulin, thyroxin, estradiol)
- Chemiluminescence immunoassay
- Western Blotting
- Southern Blotting
- Forensic Sciences
- Others
By End User
- Research and Academic Institutes
- Forensic Laboratories
- Diagnostic Laboratory
- Others
By Region
On the basis of regional analysis, the chemiluminescence imaging market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
North America region is anticipated to hold a superior position in the global chemiluminescence market owing to increasing research studies in forensic human identification by various methods such as DNA profiling, forensic radiography in which this imaging plays an important role for detection of proteomics and genomics. Additionally, high adoption of advanced technologies, growth of biotechnology and pharmaceutical industry, and large base of diagnostic laboratories is likely to contribute to the major share of North America region globally. Europe is expected to witness significant growth on the back of the launch of new products in this region.
The chemiluminescence imaging market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating the Market
- LI-COR Biosciences
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Azure Biosystems
- Berthold Technologies GmbH & Co. KG
- Bio-Rad Laboratories, Inc.
- Cleaver Scientific Ltd
- Syngene
- GE Healthcare
- Vilber Smart Imaging, Inc.
- Analytik Jena Life Science
